Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05400733 · ClinicalTrials.gov registry record · NA
Prandial Metabolic Phenotype in Adults
A NA study of Protein Metabolism, sponsored by Texas A&M University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05400733: Recruiting NA study of Protein Metabolism, sponsored by Texas A&M University.
NCT05400733 is a NA study of Protein Metabolism that is actively recruiting participants, run by Texas A&M University. The registered enrollment target is 50 participants, above the 42-participant average among 5 other Protein Metabolism trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05400733, a NA study of Protein Metabolism, is actively recruiting participants, sponsored by Texas A&M University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Previous studies suggest that changes in metabolism due to the effects of aging might serve as a potential for therapeutic agents. The investigating lab developed a pulse method combining multiple stable isotopes to study multiple metabolic pathways in the same individual simultaneously. By measuring whole-body metabolism in a large group of older adults, the investigators may be able to unravel age-related deterioration in protein turnover (synthesis and breakdown) that contributes to impaired functional capacity. Metabolic profiles could explain differences in pathways in the aging process with special interest in metabolism of amino acids as they have been associated with aging-related disorders.
Primary Outcome
Whole-body production rate measured after stable tracer administration
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Total Amino Acids
- DIETARY_SUPPLEMENT Essential Amino Acids
- DIETARY_SUPPLEMENT Essential Amino Acids + Hydroxy-methylbutyric acid (HMB)
- DIETARY_SUPPLEMENT Essential Amino Acids + Leucine
- DIETARY_SUPPLEMENT Essential Amino Acids High
Study Locations (1)
Texas
- Human Clinical Research Facility - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-06-24 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT05400733 shows while recruiting
NCT05400733 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, above the 42-participant average among 5 other Protein Metabolism trials with a reported enrollment target (19% higher).
The record links to 1 condition, with Protein Metabolism appearing as the primary indexed condition, and to 5 interventions - of which Total Amino Acids is the first listed.
NCT05400733 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05400733 about?
NCT05400733 is a clinical study titled "Prandial Metabolic Phenotype in Adults". Previous studies suggest that changes in metabolism due to the effects of aging might serve as a potential for therapeutic agents. The investigating lab developed a pulse method combining multiple stable isotopes to study multiple metabolic pathways in the same individual simultaneously. By measurin...
What is the current status of trial NCT05400733?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-06-24. Estimated completion is 2026-09.
What conditions does trial NCT05400733 study?
This clinical trial studies the following conditions: Protein Metabolism.
What interventions are being tested in trial NCT05400733?
The interventions under investigation include: Total Amino Acids (DIETARY_SUPPLEMENT), Essential Amino Acids (DIETARY_SUPPLEMENT), Essential Amino Acids + Hydroxy-methylbutyric acid (HMB) (DIETARY_SUPPLEMENT), Essential Amino Acids + Leucine (DIETARY_SUPPLEMENT), Essential Amino Acids High (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05400733?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05400733 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Protein Metabolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stable Isotopes- Adults With Obesity
RECRUITING · NA
-
Anabolic Response to Beef vs Plant Protein in (Pre)Frail Older Adults Using a Novel Stable Isotope Pulse Method
RECRUITING · NA
-
Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein
RECRUITING · NA
-
Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel Disease
COMPLETED · NA
-
Skeletal Muscle Protein Synthetic Response to Amino Acid and Peptides
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI